Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis

Fig. 1

PRISMA flow diagram showing screening and selection process. Reference: Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., et al. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. International Journal of Surgery, 88, 105,906

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us